David Benigson is CEO of Signal AI, a company using AI and media data to help executives cut through noise and drive actionable insights. Risk is no longer a four-letter word—it's a critical factor ...

The US Food and Drug Administration (FDA) on Tuesday issued final guidance meant to assist drug and medical device makers in developing risk-based monitoring strategies for clinical investigations ...

NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Dow Jones Risk & Compliance has today announced a new advanced, AI-powered solution for financial crime and third-party risk management. RiskCenter ...

Clinical trials can often take between six and seven years to complete, but that timeline isn’t always practical for the problems pharmaceutical companies are trying to solve. Additionally, six years ...

Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions. For ...

Outdated compliance programs were not designed to operate effectively in the current, dynamic threat environment. They were ...